Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1336 AL 1350

A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease

Currie AD, Wong JK, Okun MS.

NPJ Parkinsons Dis. 2024 Oct 23;10(1):195. doi: 10.1038/s41531-024-00804-0.

Dual challenge inside the womb: a case report of concomitant fetal atrio-ventricular block associated with maternal anti-SSA antibodies and fetal tachyarrhythmia diagnosed as Wolff-Parkinson-White syndrome after birth

Chícharo AT, Rebelo M, Lopes AR, Saavedra MJ, Paramés MF, Araújo AR, Cruz-Machado AR, Pinto L, Capela S.

Front Immunol. 2024 Jul 24;15:1397103. doi: 10.3389/fimmu.2024.1397103. eCollection 2024.

Surgical cryoablation of a right posteroseptal accessory pathway and removal of right atrial thrombi

Sirinvaravong N, Guo A, Hsu D, Kalbfleisch S, Augostini R, Choi K.

HeartRhythm Case Rep. 2024 Jul 9;10(10):710-713. doi: 10.1016/j.hrcr.2024.07.004. eCollection 2024 Oct.

Adjustment Disorder Presenting as Syncope in a Patient With Wolf-Parkinson White Syndrome

Van Name J.

Cureus. 2024 Nov 19;16(11):e74046. doi: 10.7759/cureus.74046. eCollection 2024 Nov.

Tumor-Induced Parkinsonism Due to a Large Meningioma Diagnosed by 99m Tc-TRODAT-1 SPECT/CT

Alipour A, Ghaedian T, Yazdani B, Rakhsha A, Ostovan VR.

Clin Nucl Med. 2024 Jun 1;49(6):e284-e285. doi: 10.1097/RLU.0000000000005178. Epub 2024 Mar 18.

Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alshammari MS, Alexiou A, Papadakis M, Bahaa MM, Batiha GE.

J Cell Mol Med. 2024 Jun;28(11):e18412. doi: 10.1111/jcmm.18412.

Prodromes in demyelinating disorders, amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer's dementia

Marrie RA, Maxwell CJ, Rotstein DL, Tsai CC, Tremlett H.

Rev Neurol (Paris). 2024 Mar;180(3):125-140. doi: 10.1016/j.neurol.2023.07.002. Epub 2023 Aug 9.

Brain structure comparison among Parkinson disease, essential tremor, and healthy controls using 7T MRI

Moon HC, Kim A, Park YS.

Medicine (Baltimore). 2024 May 10;103(19):e38139. doi: 10.1097/MD.0000000000038139.

Intermittent ventricular preexcitation in children: not always a low-risk condition

Yammine ML, Tamborrino PP, Flore F, Di Mambro C, Pazzano V, Di Marzio S, Drago F.

Europace. 2024 Oct 3;26(10):euae250. doi: 10.1093/europace/euae250.

Mapping of accessory pathways in pediatric patients with Ebstein anomaly using open-window mapping

Ezzeddine FM, Amin H, Cannon B.

HeartRhythm Case Rep. 2024 Jul 16;10(10):742-747. doi: 10.1016/j.hrcr.2024.07.014. eCollection 2024 Oct.

Update: Descriptive epidemiology of Parkinson disease

Grotewold N, Albin RL.

Parkinsonism Relat Disord. 2024 Mar;120:106000. doi: 10.1016/j.parkreldis.2024.106000. Epub 2024 Jan 8.

Disease-specific interventions: The use of cell and gene therapies for Parkinson disease

Barker RA, Buttery PC.

Handb Clin Neurol. 2024;205:171-191. doi: 10.1016/B978-0-323-90120-8.00003-4.

Case Report: Focal cryoablation vs. radiofrequency ablation in a pediatric patient with para-Hisian accessory pathway with effect from the non-coronary aortic cusp

Maksut Z, Zhanbolatkyzy R, Bakytzhanuly A, Bajgalkanova A, Ergül Y, Nuralinov O.

Front Pediatr. 2024 Aug 20;12:1405104. doi: 10.3389/fped.2024.1405104. eCollection 2024.

Beyond timing and step counting in 360° turning-in-place assessment: a scoping review

Netukova S, Horakova L, Szabo Z, Krupicka R.

Biomed Eng Online. 2024 Jan 31;23(1):13. doi: 10.1186/s12938-024-01208-0.

Global trend of nondrug and nonsedativehypnotic treatment forinsomnia: a bibliometric study

Hanzhou L, Guixing XU, Zepeng W, Ling Z, Fanrong L.

J Tradit Chin Med. 2024 Jun;44(3):595-608. doi: 10.19852/j.cnki.jtcm.20240408.002.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias